Prostaglandins and prostaglandin inhibitors for congenital heart defects

Content provided by Healthwise

Prostaglandins and prostaglandin inhibitors for congenital heart defects

Normally, a blood vessel needed only for fetal blood circulation (called the ductus arteriosus) closes off at birth. During fetal development, this blood vessel is kept open by a naturally occurring substance in the fetus's body called prostaglandin. At birth, fetal production of prostaglandin decreases and the ductus arteriosus closes.

In some premature infants, this blood vessel does not close, which is a condition called a patent (open) ductus arteriosus. These premature infants are given a prostaglandin inhibitor, a medicine to stimulate the closure of this blood vessel.

When an infant has certain other congenital heart defects, a medicine (a form of prostaglandin) is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to continue circulating until surgery or another procedure can be done to correct the related defect and allow normal blood flow.

Credits

Print Email SHARE

Author	Robin Parks, MS
Editor	Kathleen M. Ariss, MS
Associate Editor	Pat Truman, MATC
Primary Medical Reviewer	Michael J. Sexton, MD - Pediatrics
Specialist Medical Reviewer	Larry A. Latson, MD - Pediatric Cardiology
Last Updated	October 25, 2007

Print Email Twitter Facebook MySpace AIM More

Last updated:	October 25, 2007
Author:	Robin Parks, MS
Reviewed By:	Michael J. Sexton, MD - Pediatrics, Larry A. Latson, MD - Pediatric Cardiology
Editors:	Kathleen M. Ariss, MS, Pat Truman, MATC

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.